Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 5,596Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Faran Shimi Pharmaceutical

02 1Accord healthcare

03 1Acino Pharma

04 1Acorda Therapeutics

05 1Actavis Inc

06 1Alkem Laboratories

07 1Ascent Innovative Medicines

08 1Aurobindo Pharma Limited

09 6Biogen

10 4CHEMO

11 1CinnaGen Co

12 1Hikma Pharmaceuticals

13 1Intas Pharmaceuticals

14 1Merz Pharma

15 1Micro Labs Limited

16 1Neuraxpharm

17 2ORIFARM GROUP AS

18 1Pharmascience Inc.

19 1Rising Pharmaceuticals Inc

20 1Sun Pharmaceutical Industries Limited

21 1Taro Pharmaceutical Industries

22 1Teva Pharmaceutical Industries

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothFaran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.

Regulatory Info :

Registration Country : Iran

Fampridine

Brand Name :

Dosage Form : Extended-Release Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

Faran Shimi Pharmaceutical

02

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2018-07-11

Application Number : 206863

Regulatory Info : RX

Registration Country : USA

blank

03

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2017-01-23

Application Number : 206836

Regulatory Info : RX

Registration Country : USA

blank

04

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2018-07-30

Application Number : 206765

Regulatory Info : RX

Registration Country : USA

blank

05

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2017-01-23

Application Number : 206811

Regulatory Info : RX

Registration Country : USA

blank

06

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

fampridine

Brand Name : Fampyra

Dosage Form : PROLONGED-RELEASE TABLET

Dosage Strength : 10 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

07

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

09

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

10

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Bottle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

11

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

Dalfampridine

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

blank

12

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

Dalfampridine

Brand Name : Dalfyra

Dosage Form : Tablet ER.

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

13

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2018-10-24

Application Number : 206646

Regulatory Info : DISCN

Registration Country : USA

blank

14

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

DALFAMPRIDINE

Brand Name : AMPYRA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2010-01-22

Application Number : 22250

Regulatory Info : RX

Registration Country : USA

blank

15

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2019-03-11

Application Number : 210158

Regulatory Info : RX

Registration Country : USA

blank

16

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

17

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

Dalfampridine

Brand Name : Fampyra

Dosage Form : Depottablett

Dosage Strength : 10 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

18

APS Symposium
Not Confirmed
arrow
arrow
APS Symposium
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2020-07-06

Application Number : 206858

Regulatory Info : DISCN

Registration Country : USA

blank

19

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date : 2019-05-21

Application Number : 208292

Regulatory Info : RX

Registration Country : USA

blank

20

DIA 2025
Not Confirmed
arrow
arrow
DIA 2025
Not Confirmed

DALFAMPRIDINE

Brand Name : DALFAMPRIDINE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 206854

Regulatory Info :

Registration Country : USA

blank